160 related articles for article (PubMed ID: 35843021)
1. Establishment of a human induced pluripotent stem cell line (TAUi008-A) derived from a multiple sclerosis patient.
Lotila J; Hyvärinen T; Skottman H; Airas L; Narkilahti S; Hagman S
Stem Cell Res; 2022 Aug; 63():102865. PubMed ID: 35843021
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
[TBL] [Abstract][Full Text] [Related]
3. Establishment of Human Induced Pluripotent Stem Cells from Multiple Sclerosis Patients.
Begentas OC; Koc D; Kiris E
Methods Mol Biol; 2022; 2549():43-67. PubMed ID: 34988943
[TBL] [Abstract][Full Text] [Related]
4. Generation of a healthy heavy smoker patient-derived induced pluripotent stem cell line UHOMi007-A from peripheral blood mononuclear cells.
Ahmed E; Fieldès M; Bourguignon C; Mianné J; Petit A; Amel N; Foisset F; Bourdais C; Vachier I; Assou S; De Vos J; Bourdin A
Stem Cell Res; 2024 Jun; 77():103437. PubMed ID: 38723411
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
6. Generation of six multiple sclerosis patient-derived induced pluripotent stem cell lines.
Miquel-Serra L; Duarri A; Muñoz Y; Kuebler B; Aran B; Costa C; Martí M; Comabella M; Malhotra S; Montalban X; Veiga A; Raya A
Stem Cell Res; 2017 Oct; 24():155-159. PubMed ID: 29034884
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
[TBL] [Abstract][Full Text] [Related]
8. Generation of an erythroid progenitor-derived iPSC line, VRISGi002-A, from a healthy 27-year-old Vietnamese donor under a feeder-free system.
Nhung Nguyen TH; Trinh Tran TT; Luong TH; Nguyen XH
Stem Cell Res; 2022 Jul; 62():102824. PubMed ID: 35679757
[TBL] [Abstract][Full Text] [Related]
9. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
10. Derivation of a human induced pluripotent stem cell (hiPSC) line (PUMCSMi001-A) from peripheral blood mononuclear cells of one healthy female donor.
Du M; Li L; Hu Y; Mi H; Wang T
Stem Cell Res; 2021 May; 53():102312. PubMed ID: 33812336
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived stem cell line UKMi005-A (hiPSC) harboring a non-synonymous heterozygous KCNJ5 gene variant.
Kayser A; Dittmann S; van Impel A; Šarić T; Schulze-Bahr E
Stem Cell Res; 2023 Dec; 73():103223. PubMed ID: 37890333
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human induced pluripotent stem cell line (OGIi001) from peripheral blood mononuclear cells of a healthy male donor.
Zhang H; Daheron L; Cerna-Chavez R; Place EM; Huckfeldt RM; Pierce EA; Garita-Hernandez M
Stem Cell Res; 2024 Feb; 74():103280. PubMed ID: 38134577
[TBL] [Abstract][Full Text] [Related]
13. Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor.
Fieldes M; Ahmed E; Bourguignon C; Mianné J; Martin M; Arnould C; Vachier I; Assou S; De Vos J; Bourdin A
Stem Cell Res; 2020 Dec; 49():102037. PubMed ID: 33099111
[TBL] [Abstract][Full Text] [Related]
14. Human induced pluripotent stem cell (iPSC) line (HEBHMUi014-A) derived from a patient with Alzheimer's disease.
Zhang M; Yu M; Guo R; Zhang Y; Zhang X; Sun J; Zhang J; Wang X; Ma J
Stem Cell Res; 2023 Jun; 69():103116. PubMed ID: 37178573
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
[TBL] [Abstract][Full Text] [Related]
16. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease.
Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L
Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593
[TBL] [Abstract][Full Text] [Related]
17. Establishment of an induced pluripotent stem cell line (SDCHi001-A) from a healthy Chinese child donor.
Wang L; Zeng Q; Wang S; Wu D; Wang J; Zhang H; Lv X
Stem Cell Res; 2024 Feb; 74():103278. PubMed ID: 38118205
[TBL] [Abstract][Full Text] [Related]
18. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
20. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
